45 phenotypes from 3 alleles in 7 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Tg(Vil1-cre)997Gum/? Tlr5tm1.1Gewr/Tlr5tm1.1Gewr involves: C57BL/6J * C57BL/6NTac * SJL/J	abnormal colon morphology	J:229155
	abnormal gut flora balance	J:229155
	decreased colon length	J:229155
	enlarged spleen	J:229155
	increased body weight	J:229155
	increased circulating cholesterol level	J:229155
	increased circulating triglyceride level	J:229155
	increased fasting circulating glucose level	J:229155
	increased interleukin-1 beta secretion	J:229155
	increased susceptibility to colitis induced morbidity/mortality	J:229155
	increased total fat pad weight	J:229155
	large intestinal inflammation	J:229155
	polyphagia	J:229155
Tlr5tm1.1Gewr/Tlr5tm1.1Gewr Tg(Itgax-cre,-EGFP)4097Ach/? involves: C57BL/6J * C57BL/6NTac	abnormal gut flora balance	J:229155
	decreased total fat pad weight	J:229155
	normal immune system phenotype	J:229155
Tlr5tm1Aki/Tlr5tm1Aki B6.129P2-Tlr5tm1Aki	decreased interleukin-6 secretion	J:112391
	decreased interleukin-12b secretion	J:112391
	decreased susceptibility to bacterial infection	J:112391
	normal immune system phenotype	J:116763
Tlr5tm1Aki/Tlr5tm1Aki involves: 129P2/OlaHsd	abnormal gut flora balance	J:229155
	decreased colon length	J:229155
	enlarged spleen	J:229155
	increased interleukin-1 beta secretion	J:229155
	increased susceptibility to colitis induced morbidity/mortality	J:229155
Tlr5tm1Aki/Tlr5tm1Aki involves: 129P2/OlaHsd * C57BL/6	abnormal macrophage physiology	J:112671
Tlr5tm1Flv/Tlr5tm1Flv involves: 129S1/Sv	abnormal leukocyte migration	J:171379
Tlr5tm1Flv/Tlr5tm1Flv involves: 129S1/Sv * C57BL/6	abnormal adipose tissue physiology	J:158055
	abnormal cytokine secretion	J:111778
	abnormal dendritic cell physiology	J:111778
	abnormal eating behavior	J:158055
	abnormal glucose homeostasis	J:158055
	abnormal gut flora balance	J:158055
	abnormal physiological response to xenobiotic	J:158055
	abnormal response to transplant	J:111778
	decreased neutrophil cell number	J:111778
	hepatic steatosis	J:158055
	hypertension	J:158055
	increased body weight	J:158055
	increased circulating cholesterol level	J:158055
	increased circulating insulin level	J:158055
	increased circulating lipocalin 2 level	J:158055
	increased circulating triglyceride level	J:158055
	increased epididymal fat pad weight	J:158055
	increased susceptibility to autoimmune diabetes	J:158055
	increased susceptibility to bacterial infection	J:111778
	increased susceptibility to diet-induced obesity	J:158055
	increased susceptibility to induced colitis	J:158055
	increased susceptibility to induced pancreatitis	J:158055
	increased systemic arterial blood pressure	J:158055
	increased systemic arterial diastolic blood pressure	J:158055
	increased systemic arterial systolic blood pressure	J:158055
	increased total body fat amount	J:158055
	insulin resistance	J:158055
	lung inflammation	J:111778
	obese	J:158055
	polyphagia	J:158055